We are live on ! Find out more
DA

DSC Advisors Portfolio holdings

AUM $11M
1-Year Est. Return 5.88%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$314M
AUM Growth
+$10.3M
Cap. Flow
-$980K
Cap. Flow %
-0.31%
Top 10 Hldgs %
73.99%
Holding
80
New
20
Increased
31
Reduced
6
Closed
14

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$2.66M
2
DFS
Discover Financial Services
DFS
+$2.3M
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$1.2M
4
ZVRA icon
Zevra Therapeutics
ZVRA
+$1.11M
5
IWN icon
iShares Russell 2000 Value ETF
IWN
+$651K

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$6.5M
2
IAU icon
iShares Gold Trust
IAU
+$2.93M
3
NSTG
NanoString Technologies, Inc.
NSTG
+$2.48M
4
TIP icon
iShares TIPS Bond ETF
TIP
+$2.04M
5
IWD icon
iShares Russell 1000 Value ETF
IWD
+$1.15M

Sector Composition

Rank Sector Weight
1 Financials 13.61%
2 Healthcare 12.49%
3 Communication Services 6.16%
4 Technology 3.98%
5 Materials 2.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCEL icon
76
Vericel Corp
VCEL
$2.38B
– –
-174,500
Closed -$576K
XBI icon
77
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.4B
– –
-90,000
Closed -$6.95M
AABA
78
DELISTED
Altaba Inc
AABA
– –
-6,166
Closed -$336K
BTX.WS
79
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
– –
-30,085
Closed -$5K
1 2 3
4

Similar funds

RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
AG
Arctis Global San Juan, Puerto Rico $14.5M AUM 58.16% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
KM
Kabouter Management Chicago, Illinois $15.6M AUM 16.79% 1-Year Est. Return

DSC Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, DSC Advisors held 80 positions worth $314M, up 3.4% from $303M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

DSC Advisors's Q3 2017 filing shows 20 new, 31 increased, 6 reduced and 14 closed positions. Its largest new stake was SPDR Gold Trust: 21,860 shares worth $2.66M. The largest sale was CVS Health, an estimated $6.5M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.

  • DSC Advisors's largest Q3 2017 buy was SPDR Gold Trust: 21,860 shares worth $2.66M.
  • DSC Advisors added most to Zevra Therapeutics in Q3 2017, an estimated $1.11M increase.
  • DSC Advisors's biggest Q3 2017 reduction was NanoString Technologies, Inc., cutting an estimated $2.48M.
  • DSC Advisors fully exited CVS Health in Q3 2017, selling an estimated $6.5M.
  • DSC Advisors's ten largest holdings make up 74% of its $314M portfolio in Q3 2017.
  • DSC Advisors opened 20 new positions and closed 14 in Q3 2017.
  • DSC Advisors's portfolio value rose 3.4% quarter-over-quarter to $314M.

Based on DSC Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.